J. L. Rodríguez‐Lambert

Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study

G. Rábago, D. Pascual, E. Roig, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

A Randomized Multicenter Comparison of Basiliximab and Muromonab (OKT3) in Heart Transplantation: SIMCOR Study

M. Gómez-Sánchez, M. Crespo-Leiro, L. Almenar, 2006, Transplantation.

Resequencing the whole MYH7 gene (including the intronic, promoter, and 3' UTR sequences) in hypertrophic cardiomyopathy.

V. Álvarez, E. Coto, María Martín, 2012, The Journal of molecular diagnostics : JMD.

Oral glucose tolerance test as a tool for patient improvement after percutaneous coronary intervention.

E. Delgado, J. M. García-Ruíz, P. Martínez-Camblor, 2012, Revista espanola de cardiologia.

Transplantation for complex congenital heart disease in adults: a subanalysis of the Spanish Heart Transplant Registry

J. Delgado, L. Almenar, M. Crespo‐Leiro, 2012, Clinical transplantation.

Study of the safety and tolerability of Simulect® (basiliximab) versus OKT3 in heart transplantation

M. Gómez-Sánchez, E. Roig, L. Almenar, 2003 .

Clinical utility of NT-proBNP levels in late heart transplantation patients.

F. V. Álvarez, B. Prieto, N. Avello, 2010, Clinica chimica acta; international journal of clinical chemistry.